Discussion
The results of this survey were in agreement with studies emphasizing
the role of F18-FDG during COVID-19. 12-15 Some
studies reported the need for lung, bone, and inflammation -related
radiopharmaceuticals. 16-17
The results are in agreement with many studies reported many changes in
the transport of medical radioisotopes, purchasing, and preparations of
radiopharmaceuticals. The results are in agreement with the fact that
the supply, the availability of the most vital medical radioisotopes
used in radiopharmacy of nuclear medicine and in research are delayed or
stopped due to the current lockdown, extended border controls,
cancelation of most of commercial passenger flights, increments in the
cargo costs. 18-19 The results showed that it is a
must and yes there is intention to develop new radiopharmaceuticals to
detect the impact and to help to know the cause of COVID-19 pandemic and
confine it.
The COVID-19 pandemic has forced many organizations back to the drawing
board to redesign their operations and strategy. It is clear that the
pandemic is continuing to have a huge impact on the medical sector by
affecting normal operations. It has created a relatively inconvenient
environment of operations within radiopharmacy labs across the globe due
to strict guidelines that must be followed to avoid the spread of the
virus. As the rate of infection continues to increase each day, the
number of deaths also increases. The increased infection rate has caused
a strain in medical facilities. Access and demand for medical and
laboratory equipment such as radioisotopes and the preparation of
radiopharmaceuticals have drastically changed. Medical professionals
must conform to the new ways of life and accept that things are
different in order to prevent the spread of the
virus.20-21